Hims & Hers Health
HIMS
$64.22
Share price
5.16%
Change (1 day)
186.82%
Change (1 year)
Revenue for Hims & Hers Health (HIMS)
Revenue in 2025 (TTM): $1.78 Billion USD
According to Hims & Hers Health's latest financial reports the company's current revenue (TTM 
) is $1.78 Billion USD. In 2024 the company made a revenue of $1.47 Billion USD an increase over the revenue in the year 2023 that were of $0.87 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hims & Hers Health from 2020 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $1.78 B | 20.85% |
| 2024 | $1.47 B | 69.33% |
| 2023 | $0.87 B | 65.49% |
| 2022 | $0.52 B | 93.81% |
| 2021 | $0.27 B | 82.77% |
| 2020 | $0.14 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | $0.62 B | -65.16% | Jersey |
 Novavax NVAX | $1.21 B | -31.93% | 🇺🇸 USA |
 Organovo ONVO | $0.12 M | -99.99% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $21.83 M | -98.78% | 🇬🇧 UK |